“When this Government assumed office, New Zealanders were facing an uncertain future for medicine access. Pharmac had a $1.7 billion funding hole and ... From today, an estimated 112 patients will be ...

Pharmac first funded the medicine in 2020 for some people with type 2 diabetes, but from this month it will widen access to ...

Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

The medical isotope market was valued at $5.1 billion in 2022 and is expected to grow to $11.4 billion by 2032, at a CAGR of 8.8% from 2023 to 2032.

This summary highlights breakthroughs and challenges in the health sector, including advancements in asthma and breast cancer ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

A widely used pill for treating an underactive thyroid may be associated with bone loss, according to a study being presented ...

The recommended daily intake of stinging nettle should not be exceeded in order to avoid stomach and intestinal complaints ...

Robert F. Kennedy Jr. says fluoride should be removed from drinking water, but experts say the naturally occurring mineral is ...